학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 102건 | 목록 1~10
Academic Journal
Ridker, PMRevkin, JAmarenco, PBrunell, RCurto, MCiveira, FFlather, MGlynn, RJGregoire, JJukema, JWKarpov, YKastelein, JJPKoenig, WLorenzatti, AManga, PMasiukiewicz, UMiller, MMosterd, AMurin, JNicolau, JCNissen, SPonikowski, PSantos, RDSchwartz, PFSoran, HWhite, HWright, RSVrablik, MYunis, CShear, CLTardif, JCConde, DColquhoun, DMissault, LGao, RLUrina, MSolar, MJensen, HKGrobbee, DSavolainen, MSchiele, FMontalescot, GEdes, IBlake, GLotan, CMaggioni, ASavonitto, SLee, CWPons, JLLDan, GACortada, JBMellbin, LKahan, TNoble, SHwang, JJSritara, PTokgozoglu, LTarasenko, LBorer, JSBlack, HCarmena, RFurie, KLMcMurray, JNeaton, JZannad, FO'Neill, BWelty, FMcNamara, RChun, HAbbott, JDJacoby, DMcPherson, CJadbabaie, FPinto, DMcCullough, LSilverman, IESansing, LHDearborn-Tomazos, JFoody, JSchindler, JPiazza, GChakrabarti, APride, YGelfand, EBaultrukonis, DChaudhuri, SFrederich, RJohnson, MMridha, KPowell, CWang, EWei, CMAnderson, PBuonanno, MEpsley, CEvans, BFrolova, MGoetsch, MHessinger, DIkehara, EIvanac, KKizko, JLe, KMcNally-Dufort, CMorocco, TNadkarni, SNissen, TNye, RPak, RPence, DRedifer, PSchwartz, WSattler, CSchade, RSullivan, BWegner, JAlvarez, CABudassi, NVogel, DRAvaca, HConde, DGEstol, CCCJGelersztein, EGlenny, JAHershson, ARBruno, RLMaffei, LESoler, JMPZaidman, CJCarnero, GSColombo, HRJure, HOLuquez, HARamos, HRResk, JHRusculleda, MMUlla, MRCaccavo, AFarias, EFWenetz, LMMCabella, PRFCuadrado, JAChahin, MMackinnon, IJZarandon, RBSSchmidberg, JFernandez, AAMontana, OCodutti, ORGorosito, VMMaldonado, NSala, JDe La Fuente, RALCasabella, TESDi Gennaro, JPAGuerrero, RAAAlvarez, MSBerli, MBotta, CEMontenegro, EEVico, MLBegg, ALehman, RGilfillan, CPd'Emden, MMarkovic, TPSullivan, DAroney, CStranks, SNCrimmins, DSArstall, MVan Gaal, WDavis, TAylward, PEAmerena, JWilliam, MProietto, JPurnell, PWSingh, BArya, KWDart, AMThompson, PDavis, SMCarroll, PADe Looze, FJayasinghe, RBhindi, RBuysschaert, ISarens, Tvan de Borne, PScott, BPRoosen, JCools, FMissault, LHDebroye, CSchoors, DFHollanders, GSchroe, HHDe Sutter, JHermans, KCarlier, Mvan Landegem, PVerwerft, JMulleners, TDelforge, MDSoufflet, VElegeert, IDescamps, OSJanssens, SLemmens, RCDesfontaines, PScheen, AHeijmans, SCapiau, LVervoort, GCarlier, SGFaes, DAlzand, BKeuleers, SDe Wolf, LThoeng, JDe Bruyne, Lde Santos, MONFelicio, JSAreas, CAFFigueiredo, ELMichalaros, YLNeuenschwander, FCReis, GSaad, JAKormann, APMNascimento, CVPrecoma, DBAbib, Edos Santos, FRMello, YGSaraiva, JFKRech, RLCerci, RFortes, JARRossi, PRFSilva, FADEHissa, MSilva, RPde Souza, WKSBFilho, FVGMangili, OCPaiva, MSMDTumelero, RAbrantes, JAMCaramori, PRDutra, OPLeaes, PEManenti, ERPolanczyk, CAFarias, FABEMoraes, JBXRusso, LAAlves, ARDracoulakis, MDARitt, LEFSaporito, WFHerdy, AHMaia, LNSternieri, MVBBAyoub, JCABianco, HTda Costa, FAEliaschewitz, FGFonseca, FAHNakandakare, ERBonansea, TCPCastro, NMSSilva, PGMDESmith, PBotelho, RVResende, ESBarbieri, DSGHernandes, MEBajaj, HBeaudry, PBerlingieri, JCSalter, TJAjala, BAnderson, TJNanji, APandey, SDesrosiers, DGaudet, DMoran, GCsanadi, MAStAmour, ECusimano, SHalperin, FABabapulle, MVizel, SPetrella, JSpence, JDGupta, NTellier, GBourgeois, RGregoire, JCWesson, TZadra, RTwum-Barima, DYCha, JYHartleib, MCBergeron, JChouinard, GMcPherson, TPSearles, GPeterson, SRMukherjee, ALepage, SConway, JRKouz, SMDion, DPesant, YCheung, SSGoldenberg, RMAronson, RGupta, AKO'Mahoney, MPliamm, LTeitelbaum, IHoag, GNNadra, IJYared, ZYao, LCNguyen, TSaunders, KKLi, YWang, DLi, JYang, XDu, YWang, GYang, PZhang, XXu, PZhao, YChen, JLi, SLi, WZhang, LZhu, YZhang, YZhou, CWang, YLiu, FMa, YTi, ZZeng, XZhou, YCui, GLi, DXue, LJiang, JLian, YHe, YMendoza, JABonfanti, JACDada, FATUrina-Triana, MARodriguez, WRBSanchez, MLJLozno, HYTriana, EHArambula, RMSRico-Carrillo, AEGallo, HJHCatano, JSVJattin, FGMPlazas, JARGomez, JEFBotero-Lopez, RGomez, NIJMunoz, CFJPelaez, SVEraso, AMGoyes, ARBElbl, LFiserova, NVesely, JWasserburger, BBlaha, VVojacek, JMaskova, PHutyra, MVrkoc, JHala, TVodnansky, PBocek, PCifkova, RBufka, VCeska, RMachkova, MZidkova, ELukac, MMikusova, TKellnerova, IKuchar, LFerkl, RCech, VZemek, SMonhart, ZDavidsen, FJoensen, ALihn, ASRasmussen, TKWiggers, HLindgren, LMSchmidt, UGalatius, SSillesen, HSchou, JBThomsen, KKUrhammer, SJeppensen, JSchou, MMay, OSteffensen, RNielsen, WBNielesen, TJepsen, JMRai, ASykulski, RAndersen, LTRickers, HFrost, LLomholdt, JEgstrup, KWermuth, SKlausen, CLassus, JPalomaki, AKhari, JTatlisumak, TKekki, SVanttinen, EStrandberg, AValtonen, MSia, SMNerg, OPuhakka, MStrand, JTimonen, MLevola, JArstila, LTaurio, JKantola, ISuomi, JHumaloja, KAskonen, KSibon, IZemour, GGoube, PPetit, CChati, ZRange, GRabahi, FRihani, RBergerot, CRoubille, FBoye, AProbst, VFerrari, ECayla, GThouvenot, EDelarche, NCouffinhal, TCoisne, DPaillard, FElbaz, MDecoulx, EAngoulvant, DAgraou, BCaudmont, SBerrouschot, JLauer, BSchoell, ITrenk, DDerwahl, KMKhariouzov, AProepper, FStawowy, PStephan, UDStoessel, JVoehringer, HFDorsel, TStellbrink, CRinke, ANorthroff, JBourhaial, HStratmann, MWetzel, TAxthelm, CGuenzel, AWeigmann, IFaghih, MHagemann, DSchaefer, AWeber, DLuedemann, JContzen, CKornmann, MOWinkelmann, BSimon, JFelix, SBrauer, CLaufs, USchmidt, EMarten, ILicka, MHeisters, JAppel, KFKleinecke-Pohl, UKlein, CVon Hodenberg, EFMaus, OSigal, HTaeschner, HSchwimmbeck, PLemke, BPerings, CIllies, GPfuetzner, ASalbach, PHengstenberg, CKohler, AMudra, HBehnke, TBaar, MJeserich, MScholz, GNaudts, IVoller, HHerrmann, HJVon Engelhardt, CBGerke, SPohlmeier, LSchaufele, TWoehrle, JAl-Zoebi, AHoracek, TPeterfai, EKemeny, VLakatos, FBod, EAndrassy, PAndreka, PBalo, TDavidovits, ZLaszlo, ZNagy, KPapp, ASomogyi, AToldy-Schedel, EVertes, AVoros, PParagh, GMartyin, THajdu, CDeak, LFarago, KNagy, AKirschner, RKoszegi, ZZilahi, ZToth, KWittmann, IBajcsi, DReiber, IToth, LBenczur, BNagy, LSydo, TLupkovics, GOroszlan, TCrean, PMahon, NGMcAdam, BMacNeill, BKatz, ATsalihin, DVazan, AEitan, ALewis, BSGavish, DWainstein, JMosenzon, OMosseri, MVishlitzky, VAtar, SNseir, WBBrenner, HElis, AFuchs, SShimon, ISolodky, AGoldhaber, ATanne, DKnobler, HKracoff, OHHussein, OAuriel, EChorin, ESharir, TBitzur, RShechter, MAntonicelli, RFranceschini, EPorcu, MSesti, GMaggiolini, SSalvioni, AFilardi, PPTrimarco, BAverna, MPasqualini, LPirro, MPantaleoni, MPiovaccari, GArca, MFedele, FRoncon, LAnselmi, MSganzerla, PMorocutti, GBonora, EDimas, ALEsperon, GALMorales-Villegas, EIsunza, JMRBeltran, LGMMolina, CAAGarcia, DKRuiz, LANReyna, LSIbarra, MODSoto, JRLGonzalez-Ortiz, MHerrera-Marmolejo, MRamos, SAJRamos-Lopez, GAStobschinski, CAAguilarSalinas, CAAlpizar-Salazar, MJimenez-Sanchez, MMijangos, JHSMoreno, ERECastillo, AGHernandez, PAGGonzalez-Gonzalez, JGCharles, CMRLopez, HGVEscobar, PLNdel Campo, ALMMontes, BECBucio, AMRodriguez-Briones, IAmione, GTOrtiz, RVCeballos, RILRosas, ELBax, WAAlhakim, Mvan de Wiel, ALiem, SSGroutars, RGEJHerrman, JPRHovingh, GKvan de Wetering, MLvan Royen, NGroenemeijer, BEHoedemaker, GSchaap, JRonner, EAngun, MMairuhu, ATVan Alem, APMartens, FMACHeijmeriks, JAvan Hal, JMCSchoofs, MWden Hartog, FRKentgens, SPost, JCLouwerenburg, JWvan Rossum, PViergever, EPDonders, SHKamphuisen, PWvan Beek, ENijmeijer, RLenderink, TSchreuder, TKuijper, AFThe, SHHof-Wiersma, JJVTichelaar, PWesterndorp, IBreedveld, RWRomer, TJBogaard, KVan Koningsbruggen, PKroon, AAHoogslag, PARensing, BJCramer, ERemmen, JJRiksen, NPBokern, MJCabezas, MCMulder, HNierop, PRvan Kempen, WWZoet-Nugteren, SKvan Daele, MESwart, HPvan der Zwaan, CTHermans, WRMagro, Mvan de Wal, RMAHassink, RJVisseren, FLVeenendaal, ADe Nooijer, CTroquay, RPImholz, BPvan der Meer, PVisser, RPvan Leendert, RJGosselink, MABaker, JBenatar, JRKerr, JPryke, JRScott, RSMillar-Corte, GDWilliams, MMontgomery, BVenter, DJTernouth, IFDeCaigney, SCHart, HHCorin, AGarden, PISheahan, DHarding, SAKorecki, JSupronik, JStyczkiewicz, MBijata-Bronisz, RRusicka, TWalczak, MKrolikowski, ZOstrowski, JLukaszewicz, MPrzekwas-Jaruchowska, MZieba, BMiekus, POrkwiszewska-Nalewajko, APiepiorka, MKubalski, PWychota, KBlach, EOchala, AOkopien, BWronska, DJanion, MCzarnecka, DKolodziejczyk, JKonieczynska, MLanda, KMirek-Bryniarska, ENecki, MPasternak, DARozpondek, PTrebacz, JWalczewska, JSidor, MBroncel, MDrozdz, JKosmider, MSaryuszWolska, MKucharska, DOpalinska, EPijanowski, ZWozniak, IBanaszkiewicz, KKlecha, AHorodecki, MPiskorz-Wapinska, JKobielusz-Gembala, IKim, MHKim, DKCho, BRKim, KSHer, SHLee, SRhee, MYKim, KKang, WCKim, DHCho, YSKim, SHRim, SJTahk, SJJeon, HKYoon, JMociran, MPop, CFMinescu, BAndrei, LDRadoi, MCalin, ACiomag, RMCopaci, IFruntelata, AGPopescu, MTivadar, SRoman, GAvram, RIMistodie, CVMorosanu, MPopa, ARPopescu, MLPopoviciu, MSTase, ABusegeanu, MPopescu, ASzilagyi, ISitterli-Natea, CNMaximov, DMMunteanu, MNegrisanu, GDKuzin, APopov, DShapovalova, JVishneva, EShutemova, EPasechnik, EBogdanov, EKhasanov, NBarbarash, OLShangina, OATarasov, NSolonev, OKosmacheva, EChernyatina, MAGinzburg, MBlokhin, ABulanova, NDrapkina, OMGordeev, IGLibov, IALomakin, NPanchenko, EShogenov, ZSZateyshchikov, DKlein, GMotylev, IBelenkiy, DIDemin, ANikolaev, KYOleynikov, VZrazhevskiy, KKatelnitskiy, IKhaisheva, LAksentiev, SNedoshivin, APopova, VBAgafina, ASBallyuzek, MBaranova, EBurova, NEryshev, SFilippov, AGoloshchekin, BMKonstantinov, VKostenko, VASimanenkov, VIVolkova, ADuplyakov, DReshetko, OShvarts, YKuznetsov, VASamoylova, YGTolkacheva, VShalaev, SVKhokhlov, ALMalygin, AShilkina, NPYakusevich, VVMargoczy, RZubek, VDzupina, ADubrava, JDulkova, KFabryova, LGaspar, LKamensky, GKokles, MRaslova, KSoosova, IStevlik, JStrbova, JSumbal, JUhliar, RMicik, JTruban, JFedacko, JPastrnakova, EPella, DFazekas, FAmbrovicova, VKycina, PMartinka, ENociar, JBelicova, MBanik, MKanderkova, DHranai, MDuris, TKrahulec, BBenacka, JVinanska, DRoskova, ESkripova, DMacek, VVohnout, BBuganova, IEngelbrecht, JMPretorius, MMEbrahim, IOBayat, JGanesh, SRanjith, NCoetzer, TFJacovides, ADistiller, LAHellig, FSEngelbrecht, IVMahomed, AABlignault, SCBurgess, LJKotze, HJvan Nieuwenhuizen, EMusungaie, DBEmanuel, Svan der Walt, EPretorius, CERoos, JSRoux, SMBadat, AEFouche, LVahed, YAKvan Resburg, DJvan Zyl, LJGonzalez, ASDiaz, JLSegura, TSerrano, MBRodrigues, JBMolto-Jorda, JMEscribano, JRRDGarri, FSCoronado, JLBSaenz, MSGCuixart, CBMarimon, XGMMorgaez, JDGSantos, OMGonzalez, JRSobrino-Martinez, JFernandez, JECNarejos, SGarcia, SSMartinez, PPCamos, RFMartinez, VMGuerrero, DBDeben, FMBelmonte, AVGarcia, JDMHinojosa, JARMateu, EMFillat, ARCSala, XPMartori, RADiez, MBCano, CLDiz, FWJuanatey, CGWalther, LAASDiaz, JDGPuig, JGGimeno, EJPerez, IPSuarez-Fernandez, CTunon, JGomez, JLZSanfiel, MABVilla, JMEMartin, MDLopez, MDGarcia, JMHMadueno, FJTParedes, MPVillar, JAGonzalez, MJBVera, TVRPovedano, STAlvarez, JSVia, LMIniesta, ARMasana, LBargallo, EVGomez, CCJuanatey, JRGFernandez, JMCMayor, CDGarcia, SDHernandez, MDJPortillo, CMGrijalvo, OMDe Castro, RLlaurado, ETAmate, JMPRiera, MTMurillo, FCLinderfalk, CCuriac, DSaldeen-Nilehn, KKoskinen, PKhalili, PTortensson, ILindholm, CJLuts, AKoskinen, PTGottsater, APersson, BEMooe, TLarnefeldt, HBoman, KCrisby, MRasmanis, GTengmark, BOWitt, NHagstrom, EViklund, JMuller, CMach, FBurnier, MNanchen, DWuerzner, GBanyai, MMoccetti, TMiserez, ARBilz, SWeber, KLai, WTChang, KCUeng, KCTsai, WCChiang, CEHou, CPei, DKrittayaphong, RKiatchoosakun, SSrimahachota, SBoonyavarakul, AJintapakorn, WGullu, HOnrat, EErkan, AFDemirci, DSari, RCeyhan, CAri, HAraz, MDegertekin, MGoktekin, OUresin, AYYigit, ZAkdeniz, BComlekci, AKayikcioglu, MSahin, TOzcan, TDurakoglugil, EAsamoah-Owusu, NReed, RBakhai, ADixon, LSharma, RAvornyo, AAJones, AFLip, GClark, RBanerjee, MWakeling, JArden, CBlagden, MDWalukiewica, PMarshall, AMaxwell, TGGunstone, AEKadr, HHPatle, RArif, IJhund, PSMcKaig, GDouglas, FMierzejewski, LTurner, WSathyapalan, TIvan, PManoj, ARice, SCollier, DJNair, DRThom, SFiore, GDe Belder, MPrice, DSobolewska, JMartin, STakhar, AMoriarty, AKondagunta, VMyhill, TGibson, JMCecil, JTHalcox, JAnnamalai, NGorog, DAMcCormack, TPegge, NField, AAdams, FKlein, JJBusch, RSBretton, EMJaffrani, NSalacata, AAssadourian, AGogia, HSDyke, CKRubenfire, MEssandoh, LKWelker, JALedesma, GLupovitch, SDelgado, JPHendrix, ELQuyyumi, AARiesenberg, RARobertson, DGWeinstein, DLWeiss, RCasaubon, LGammon, RSBrar, HSBittar, GDGuarnieri, TTIncer, CSQuraishi, AMSaeed, SAlbert, MSotolongo, RPBernard, JVKarlsbergg, RPLepor, NEKirby, WEMcLean, BMiller, APOvalle, FTownsend, JCBeckett, PLEaves, WBWest, SHKosinski, EJZarich, SWMahal, SSMaw, KMaynard, KMChen, JCGelormini, JGottlieb, DWGabra, NWNarayan, PSparks, JField, JCWillits, VLO'Steen, MBPasquini, JASensebrenner, JWYarows, SAHiotis, LJagielo, TJLevinson, DJDiller, PMKereiakes, DJTurner, TAVincent, SCamp, ADDenker, PSManning, MBRocco, MBStamps, HBStrader, JRUusinarkaus, KTKennett, JDLeichter, SBMcNeil, DLSchumacher, DRChang, AREllison, HSUpdegrove, JDHamroff, GSKay, JSMarar, IEFlores, ESaini, SAbdullah, SBerk, MRFordan, SJoshi, PHMcCullough, PAAReynolds, RDRosenstock, JSachson, RAShammas, NFishbein, GJRandall, WJHenderson, DANash, MLBarker, BACohen, SSSeidman, BOdekirk, LLGrillo, RSMartinez, LMMultani, PAlwine, LKMcGarvey, JFMollerus, MEMiller, ABKotek, LWChanglani, MZavaro, SHMunoz, FMehta, PMHelm, RJFarhat, NZFarsad, RRaoof, TJShultz, JHGeohas, JGAllaw, MADela Llana, AGutmann, JEInzerello, ATAlappat, PGeorge, ARHaddad, TMLillestol, MJGrodman, RPeniston, JHWadud, KGarcia, BHamilton, MELerman, SPerloff, DEGraff, ASaxena, SAlvarado, OPMalik, AReddy, RDKinzfogl, GCornett, GMNorwood, PCGilbert, JMWillis, JGMcGrew, FSharma, SCastro, MACucher, FHAltafullah, IMKhurana, SKnutson, TJKinnaman, SJStuckey, TPudi, KKMayfield, RKFunk, GSNixon, WADor, IBoyett, BESrivastava, SElosegui, AMIsserman, SMCheek, HBPromisloff, SDTami, LFZeig, SFitz-Patrick, DDave, KNAhmad, AArain, SBallantyne, CMDoshi, AEl Hafi, SEFeldman, JFragoso, VGGilford, THoffman, ASPouzar, JEVivekananthan, KAnsari, SHStrzinek, RACrater, TARobinson, JGFulmer, JJPatel, AMPereira, ESStich, MASultan, SGeskin, GRuoff, GEGillespie, EBybee, KAMoriarty, PMSavin, VAgaiby, JMMelucci, MBJantzi, CMDavidson, ESmith, WBTreasure, CBWakefield, PHDeck, KEdris, MAGilmore, RMSeep, MKAndersen, JLDetweiler, RORosenfeld, JCStrobl, DJSteinhoff, JPAdams, AEstevez, RMolin, CJKim, CYDy, JFox, KEFarris, NRWayne, JDWhitney, RTRandhawa, PMMego, DMMacDolnald, LCaputo, RPRigolosi, RVanNatta, BPacheco, TREl-Shahawy, MGonzalez, EJGuice, MJCherlin, RSBays, HEShoukfeh, MMorris, FHLoy, JVora, SKStaab, PKFrisoli, AKimmel, MACohen, AJGreen, CBWhitlock, LButuk, DJMcCartney, MJAbles, LRAcosta, RAlvarez, JGBarrera, CMBenitez, OBerenguer, RABreton, CFChiong, RDelgado, MIDufreny, AFialkow, JAFranczek, SFrias, JJIglesias, CLandron-Garcia, LLlerena, SNMartinez, RFMiranda, AAMorytko, JARodriguez, IJSotolongo, RSuarez-Sarmiento, ATerrelonge, AEVaca, CEVenereo, JMVerdeza, CZeno, MLChilka, SFelten, WRHartman, ANShayani, SSDuprez, DKnickelbine, TChambers, JDCone, CLBroughton, RNapoli, MCSeaton, BLSmith, SKReedy, MAKesani, MKNicol, PRStringam, SOTalano, JVBarnum, ODesai, VMontero, MJacks, RKKostis, JBOwen, JGMakam, SKGrosman, IUnderberg, JAMasri, BEPeters, SSSerje, JLenhard, MJJGlover, RParaboschi, CFLim, EHConnery, LKipgen, WBravo, PDiGiovanna, MJTayoum, HGabriel, JDAriani, MKRobinson, MFClemens, PCCorder, CNSchifferdecker, BTahirkheli, NKHurling, RTRendell, MSShivaswamy, VMadu, IJDahl, CFAyesu, KKim, CBarettella, MBJamidar, HABloom, SAVora, KNOng, STAggarwala, GSack, GBlaze, KKrichmar, PMurcia, ATeltser, MVillaman-Bencosme, YFahdi, IEWilliams, DGLain, ELGarcia, HLKarim, SNFrancyk, DMGordon, MBPalchick, BAMcKenzie, MEGimness, MPGreiff, JRuiz-R, LVazquez-Tanus, JBSchlager, DConnelly, TSoroka, EHastings, WLO'Dea, DJPurdy, DAJackson, BArcanese, MLStrain, JESchmedtje, JFDavis, MGLabroo, APrasada, SScott, DLVukotic, GAkhtar, NLarsen, DCRhudy, JMZebrack, JSBailey, SRGrant, DCMora, APerez, JAReyes, RGSutton, JCBrandon, DMFirst, BPrianRisser, JAClaudio, JFigueroa-Cruz, WLSosa-Padilla, MATan, AETraboulssi, MAMorcos, NCGlaser, LABredlau, CERamos, MJKandath, DDKaluski, EAkright, LRictor, KWPluto, TMHermany, PRBellingar, BClark, GBHerrod, JNGoisse, MHook, MBarrington, PLentz, JDSingal, DKGleason, GPLipetz, RSSchuchard, TNBonner, JHForgosh, LBLefebvre, GCPierpoint, BERadin, DMStoller, SRSegall, NShah, SARamstad, DSNisnisan, JMTrippett, JMBenjamin, SALabissiere, JCNashed, ANMaaieh, MAslam, AAMandviwala, MBudoff, MJFrench, WJVlach, JJDeStefano, PBayron, CJFraser, NJSandberg, JHFagan, TCPeart, BCSuryanarayana, PGGupta, DKLee, MWBertolet, BDHartley, PAKelberman, MBehmanesh, BBuynak, RJChochinov, RHSteinberg, AAChandna, HBjasker, KRPerlman, RLBall, EMPock, JSingh, SBaldari, DKaster, SLovell, JPHorowitz, BSGorman, TAPham, DNLandzberg, JSMootoo, KIMoon, EKrawczyk, JAlfieri, ADJanik, MJHerrington, DMKoilpillai, RNWaxler, ARHoffman, DASahul, ZHGumbiner, BCropp, AFujita, KGarzone, PImai, KLevisetti, MPlowchalk, DSasson, SSkaggs, JSweeney, KVincent, J
The New England journal of medicine. 376(16):1527-1539
Academic Journal
Lin NU; Dana-Farber Cancer Institute, Boston, Massachusetts.; Murthy RK; MD Anderson Cancer Center, Houston, Texas.; Abramson V; Vanderbilt University Medical Center, Nashville, Tennessee.; Anders C; Duke Cancer Institute, Durham, North Carolina.; Bachelot T; Centre Léon Bérard, Lyon, France.; Bedard PL; University Health Network, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Borges V; University of Colorado Cancer Center, Aurora.; Cameron D; Edinburgh Cancer Research Centre, Edinburgh, United Kingdom.; Carey LA; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina.; Chien AJ; University of California at San Francisco, San Francisco.; Curigliano G; Istituto Europeo di Oncologia, IRCCS, Milano, Italy.; University of Milano, Milano, Italy.; DiGiovanna MP; Yale Cancer Center, New Haven, Connecticut.; Gelmon K; British Columbia Cancer-Vancouver Centre, Vancouver, British Columbia, Canada.; Hortobagyi G; MD Anderson Cancer Center, Houston, Texas.; Hurvitz SA; David Geffen School of Medicine at UCLA/Jonsson Comprehensive Cancer Center, Los Angeles, California.; Krop I; Dana-Farber Cancer Institute, Boston, Massachusetts.; Yale Cancer Center, New Haven, Connecticut.; Loi S; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Loibl S; German Breast Group, Neu-Isenburg, Germany.; Mueller V; Universitaetsklinikum Hamburg-Eppendorf, Hamburg, Germany.; Oliveira M; Hospital Universitario Vall D'Hebron, Barcelona, Spain.; Paplomata E; Carbone Cancer Center, University of Wisconsin, Madison.; ICON Plc, Blue Bell, Pennsylvania.; Pegram M; Stanford Cancer Institute, Palo Alto, California.; Slamon D; David Geffen School of Medicine at UCLA/Jonsson Comprehensive Cancer Center, Los Angeles, California.; Zelnak A; Northside Hospital, Sandy Springs, Georgia.; Ramos J; Seagen Inc, Bothell, Washington.; Feng W; Seagen Inc, Bothell, Washington.; Winer E; Dana-Farber Cancer Institute, Boston, Massachusetts.; Yale Cancer Center, New Haven, Connecticut.
Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE
Academic Journal
Mamounas EP; NSABP Foundation and; Department of Surgery, Orlando Health UF Health Cancer Center, Orlando, USA. Electronic address: terry.mamounas@orlandohealth.com.; Untch M; AGO-B and Department of Gynecologic Oncology, HELIOS Klinikum Berlin Buch, Berlin, Germany.; Mano MS; Department of Radiology and Oncology, Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil.; Huang CS; Department of Surgery, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.; Geyer CE Jr; NSABP Foundation and; NSABP Foundation and Department of Internal Medicine, Division of Hematology and Medical Oncology, Houston Methodist Cancer Center, Houston, USA.; von Minckwitz G; GBG, Neu-Isenburg, Germany.; Wolmark N; NSABP Foundation and; NSABP Foundation and Department of Surgery, The University of Pittsburgh, Pittsburgh, USA.; Pivot X; ICANS, Strasbourg, France.; Kuemmel S; Breast Unit Kliniken Essen-Mitte, Essen, Germany; Klinik für Gynäkologie mit Brustzentrum Charité-Universitätsmedizin Berlin, Berlin, Germany.; DiGiovanna MP; Yale University School of Medicine, Yale Cancer Center and Smilow Cancer Hospital, New Haven, USA.; Kaufman B; Oncology Division, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.; Kunz G; GBG, Neu-Isenburg, Germany; St. Johannes Hospital Dortmund, Dortmund, Germany.; Conlin AK; NSABP Foundation and; NSABP Foundation and Department of Medical Oncology, Providence Cancer Institute, Portland, USA.; Alcedo JC; Department of Clinical Oncology, Centro Hemato Oncologico, Panama City, Panama.; Kuehn T; AGO-B and Klinikum Esslingen, Esslingen, Germany.; Wapnir I; NSABP Foundation and; NSABP Foundation and Stanford University School of Medicine, Stanford, USA.; Fontana A; Division of Medical Oncology, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.; Hackmann J; GBG, Neu-Isenburg, Germany; Marien-Hospital Witten, SEG, Witten, Germany.; Polikoff J; NSABP Foundation and; NSABP Foundation and Department of Hematology/Oncology, Kaiser Permanente, San Diego, USA.; Saghatchian M; Breast Cancer Department, Institut Gustave Roussy, Villejuif, France.; Brufsky A; NSABP Foundation and; NSABP Foundation and Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, USA.; Yang Y; Division of Hematology-Oncolog, Taichung Veterans General Hospital and School of Medicine, China Medical University, Taichung City, Taiwan.; Zimovjanova M; Department of Oncology, Charles University and General University Hospital, Prague, Czech Republic.; Boulet T; Department of Biostatistics, F. Hoffmann-La Roche, Basel, Switzerland.; Liu H; Product Development Safety, Genentech, Inc., South San Francisco, USA.; Tesarowski D; Product Development Oncology, Genentech, Inc., South San Francisco, USA.; Lam LH; Product Development Oncology, Genentech, Inc., South San Francisco, USA.; Song C; Product Development Oncology, Genentech, Inc., South San Francisco, USA.; Smitt M; Product Development Oncology, Genentech, Inc., South San Francisco, USA; Seattle Genetics, South San Francisco, USA.; Loibl S; GBG, Neu-Isenburg, Germany; Center for Haematology and Oncology Bethanien, Frankfurt, Germany.
Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Academic Journal
Kunst N; Department of Health Management and Health Economics, University of Oslo, Oslo, Norway.; Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale School of Medicine, New Haven, Connecticut.; Public Health Modeling Unit, Yale University School of Public Health, New Haven, Connecticut.; Department of Epidemiology and Data Science, Amsterdam University Medical Centers, Amsterdam, the Netherlands.; Wang SY; Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale School of Medicine, New Haven, Connecticut.; Department of Chronic Disease Epidemiology, Yale University School of Public Health, New Haven, Connecticut.; Hood A; Smilow Cancer Hospital, Yale New Haven Hospital, New Haven, Connecticut.; Mougalian SS; Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale School of Medicine, New Haven, Connecticut.; Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut.; DiGiovanna MP; Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut.; Adelson K; Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut.; Pusztai L; Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut.
Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE
Academic Journal
von Minckwitz G; From the German Breast Group, Neu-Isenburg (G.M., S.L., H.H.F., P.W.), the Center for Hematology and Oncology Bethanien, Frankfurt (S.L.), the AGO-B and HELIOS Klinikum Berlin-Buch, Berlin (M.U.), the National Center for Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg (A.S.), Evangelische Kliniken Gelsenkirchen, Gelsenkirchen (H.H.F.), the Arbeitsgemeinschaft Gynäkologische Onkologie - Breast and Sana Klinikum Offenbach, Offenbach (C.J.), the Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen (P.A.F.), and Mammazentrum Hamburg am Krankenhaus Jerusalem, Hamburg (P.W.) - all in Germany; the National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan (C.-S.H.); Instituto do Câncer do Estado de São Paulo, São Paulo (M.S.M.); the National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation and Orlando Health University of Florida Health Cancer Center, Orlando (E.P.M.); the NSABP Foundation and Allegheny Health Network Cancer Institute (N.W.) and the NSABP Foundation and University of Pittsburgh Cancer Institute, School of Medicine (P.R.), Pittsburgh; Hospital Universitario La Paz-Instituto de Investigación Hospital Universitario La Paz, Madrid (A.R.); Institut Régional du Cancer de Montpellier, Université de Montpellier, INSERM Unité 1194, Montpellier, France (W.J.); the NSABP Foundation and Providence Portland Medical Center, Portland, OR (A.K.C.); the National Cancer Institute, Mexico City (C.A.-S.); the NSABP Foundation and Stanford University School of Medicine, Stanford (I.L.W.), and Genentech, South San Francisco (L.H.L., D.T., M.S., S.M.S.) - both in California; Yale University School of Medicine, Yale Cancer Center, and Smilow Cancer Hospital, New Haven, CT (M.P.D.); the Ireland Cooperative Oncology Research Group, Dublin (J.P.C.); Fudan University Shanghai Cancer Center (Z.S.) and Roche (China) Holding (H.W.), Shanghai; the Cancer Center Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy (E.R.C.); F. Hoffmann-La Roche, Welwyn Garden City, United Kingdom (H.D.); and the NSABP Foundation and Virginia Commonwealth University Massey Cancer Center, Richmond (C.E.G.).; Huang CS; From the German Breast Group, Neu-Isenburg (G.M., S.L., H.H.F., P.W.), the Center for Hematology and Oncology Bethanien, Frankfurt (S.L.), the AGO-B and HELIOS Klinikum Berlin-Buch, Berlin (M.U.), the National Center for Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg (A.S.), Evangelische Kliniken Gelsenkirchen, Gelsenkirchen (H.H.F.), the Arbeitsgemeinschaft Gynäkologische Onkologie - Breast and Sana Klinikum Offenbach, Offenbach (C.J.), the Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen (P.A.F.), and Mammazentrum Hamburg am Krankenhaus Jerusalem, Hamburg (P.W.) - all in Germany; the National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan (C.-S.H.); Instituto do Câncer do Estado de São Paulo, São Paulo (M.S.M.); the National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation and Orlando Health University of Florida Health Cancer Center, Orlando (E.P.M.); the NSABP Foundation and Allegheny Health Network Cancer Institute (N.W.) and the NSABP Foundation and University of Pittsburgh Cancer Institute, School of Medicine (P.R.), Pittsburgh; Hospital Universitario La Paz-Instituto de Investigación Hospital Universitario La Paz, Madrid (A.R.); Institut Régional du Cancer de Montpellier, Université de Montpellier, INSERM Unité 1194, Montpellier, France (W.J.); the NSABP Foundation and Providence Portland Medical Center, Portland, OR (A.K.C.); the National Cancer Institute, Mexico City (C.A.-S.); the NSABP Foundation and Stanford University School of Medicine, Stanford (I.L.W.), and Genentech, South San Francisco (L.H.L., D.T., M.S., S.M.S.) - both in California; Yale University School of Medicine, Yale Cancer Center, and Smilow Cancer Hospital, New Haven, CT (M.P.D.); the Ireland Cooperative Oncology Research Group, Dublin (J.P.C.); Fudan University Shanghai Cancer Center (Z.S.) and Roche (China) Holding (H.W.), Shanghai; the Cancer Center Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy (E.R.C.); F. Hoffmann-La Roche, Welwyn Garden City, United Kingdom (H.D.); and the NSABP Foundation and Virginia Commonwealth University Massey Cancer Center, Richmond (C.E.G.).; Mano MS; From the German Breast Group, Neu-Isenburg (G.M., S.L., H.H.F., P.W.), the Center for Hematology and Oncology Bethanien, Frankfurt (S.L.), the AGO-B and HELIOS Klinikum Berlin-Buch, Berlin (M.U.), the National Center for Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg (A.S.), Evangelische Kliniken Gelsenkirchen, Gelsenkirchen (H.H.F.), the Arbeitsgemeinschaft Gynäkologische Onkologie - Breast and Sana Klinikum Offenbach, Offenbach (C.J.), the Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen (P.A.F.), and Mammazentrum Hamburg am Krankenhaus Jerusalem, Hamburg (P.W.) - all in Germany; the National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan (C.-S.H.); Instituto do Câncer do Estado de São Paulo, São Paulo (M.S.M.); the National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation and Orlando Health University of Florida Health Cancer Center, Orlando (E.P.M.); the NSABP Foundation and Allegheny Health Network Cancer Institute (N.W.) and the NSABP Foundation and University of Pittsburgh Cancer Institute, School of Medicine (P.R.), Pittsburgh; Hospital Universitario La Paz-Instituto de Investigación Hospital Universitario La Paz, Madrid (A.R.); Institut Régional du Cancer de Montpellier, Université de Montpellier, INSERM Unité 1194, Montpellier, France (W.J.); the NSABP Foundation and Providence Portland Medical Center, Portland, OR (A.K.C.); the National Cancer Institute, Mexico City (C.A.-S.); the NSABP Foundation and Stanford University School of Medicine, Stanford (I.L.W.), and Genentech, South San Francisco (L.H.L., D.T., M.S., S.M.S.) - both in California; Yale University School of Medicine, Yale Cancer Center, and Smilow Cancer Hospital, New Haven, CT (M.P.D.); the Ireland Cooperative Oncology Research Group, Dublin (J.P.C.); Fudan University Shanghai Cancer Center (Z.S.) and Roche (China) Holding (H.W.), Shanghai; the Cancer Center Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy (E.R.C.); F. Hoffmann-La Roche, Welwyn Garden City, United Kingdom (H.D.); and the NSABP Foundation and Virginia Commonwealth University Massey Cancer Center, Richmond (C.E.G.).; Loibl S; From the German Breast Group, Neu-Isenburg (G.M., S.L., H.H.F., P.W.), the Center for Hematology and Oncology Bethanien, Frankfurt (S.L.), the AGO-B and HELIOS Klinikum Berlin-Buch, Berlin (M.U.), the National Center for Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg (A.S.), Evangelische Kliniken Gelsenkirchen, Gelsenkirchen (H.H.F.), the Arbeitsgemeinschaft Gynäkologische Onkologie - Breast and Sana Klinikum Offenbach, Offenbach (C.J.), the Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen (P.A.F.), and Mammazentrum Hamburg am Krankenhaus Jerusalem, Hamburg (P.W.) - all in Germany; the National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan (C.-S.H.); Instituto do Câncer do Estado de São Paulo, São Paulo (M.S.M.); the National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation and Orlando Health University of Florida Health Cancer Center, Orlando (E.P.M.); the NSABP Foundation and Allegheny Health Network Cancer Institute (N.W.) and the NSABP Foundation and University of Pittsburgh Cancer Institute, School of Medicine (P.R.), Pittsburgh; Hospital Universitario La Paz-Instituto de Investigación Hospital Universitario La Paz, Madrid (A.R.); Institut Régional du Cancer de Montpellier, Université de Montpellier, INSERM Unité 1194, Montpellier, France (W.J.); the NSABP Foundation and Providence Portland Medical Center, Portland, OR (A.K.C.); the National Cancer Institute, Mexico City (C.A.-S.); the NSABP Foundation and Stanford University School of Medicine, Stanford (I.L.W.), and Genentech, South San Francisco (L.H.L., D.T., M.S., S.M.S.) - both in California; Yale University School of Medicine, Yale Cancer Center, and Smilow Cancer Hospital, New Haven, CT (M.P.D.); the Ireland Cooperative Oncology Research Group, Dublin (J.P.C.); Fudan University Shanghai Cancer Center (Z.S.) and Roche (China) Holding (H.W.), Shanghai; the Cancer Center Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy (E.R.C.); F. Hoffmann-La Roche, Welwyn Garden City, United Kingdom (H.D.); and the NSABP Foundation and Virginia Commonwealth University Massey Cancer Center, Richmond (C.E.G.).; Mamounas EP; From the German Breast Group, Neu-Isenburg (G.M., S.L., H.H.F., P.W.), the Center for Hematology and Oncology Bethanien, Frankfurt (S.L.), the AGO-B and HELIOS Klinikum Berlin-Buch, Berlin (M.U.), the National Center for Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg (A.S.), Evangelische Kliniken Gelsenkirchen, Gelsenkirchen (H.H.F.), the Arbeitsgemeinschaft Gynäkologische Onkologie - Breast and Sana Klinikum Offenbach, Offenbach (C.J.), the Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen (P.A.F.), and Mammazentrum Hamburg am Krankenhaus Jerusalem, Hamburg (P.W.) - all in Germany; the National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan (C.-S.H.); Instituto do Câncer do Estado de São Paulo, São Paulo (M.S.M.); the National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation and Orlando Health University of Florida Health Cancer Center, Orlando (E.P.M.); the NSABP Foundation and Allegheny Health Network Cancer Institute (N.W.) and the NSABP Foundation and University of Pittsburgh Cancer Institute, School of Medicine (P.R.), Pittsburgh; Hospital Universitario La Paz-Instituto de Investigación Hospital Universitario La Paz, Madrid (A.R.); Institut Régional du Cancer de Montpellier, Université de Montpellier, INSERM Unité 1194, Montpellier, France (W.J.); the NSABP Foundation and Providence Portland Medical Center, Portland, OR (A.K.C.); the National Cancer Institute, Mexico City (C.A.-S.); the NSABP Foundation and Stanford University School of Medicine, Stanford (I.L.W.), and Genentech, South San Francisco (L.H.L., D.T., M.S., S.M.S.) - both in California; Yale University School of Medicine, Yale Cancer Center, and Smilow Cancer Hospital, New Haven, CT (M.P.D.); the Ireland Cooperative Oncology Research Group, Dublin (J.P.C.); Fudan University Shanghai Cancer Center (Z.S.) and Roche (China) Holding (H.W.), Shanghai; the Cancer Center Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy (E.R.C.); F. Hoffmann-La Roche, Welwyn Garden City, United Kingdom (H.D.); and the NSABP Foundation and Virginia Commonwealth University Massey Cancer Center, Richmond (C.E.G.).; Untch M; From the German Breast Group, Neu-Isenburg (G.M., S.L., H.H.F., P.W.), the Center for Hematology and Oncology Bethanien, Frankfurt (S.L.), the AGO-B and HELIOS Klinikum Berlin-Buch, Berlin (M.U.), the National Center for Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg (A.S.), Evangelische Kliniken Gelsenkirchen, Gelsenkirchen (H.H.F.), the Arbeitsgemeinschaft Gynäkologische Onkologie - Breast and Sana Klinikum Offenbach, Offenbach (C.J.), the Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen (P.A.F.), and Mammazentrum Hamburg am Krankenhaus Jerusalem, Hamburg (P.W.) - all in Germany; the National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan (C.-S.H.); Instituto do Câncer do Estado de São Paulo, São Paulo (M.S.M.); the National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation and Orlando Health University of Florida Health Cancer Center, Orlando (E.P.M.); the NSABP Foundation and Allegheny Health Network Cancer Institute (N.W.) and the NSABP Foundation and University of Pittsburgh Cancer Institute, School of Medicine (P.R.), Pittsburgh; Hospital Universitario La Paz-Instituto de Investigación Hospital Universitario La Paz, Madrid (A.R.); Institut Régional du Cancer de Montpellier, Université de Montpellier, INSERM Unité 1194, Montpellier, France (W.J.); the NSABP Foundation and Providence Portland Medical Center, Portland, OR (A.K.C.); the National Cancer Institute, Mexico City (C.A.-S.); the NSABP Foundation and Stanford University School of Medicine, Stanford (I.L.W.), and Genentech, South San Francisco (L.H.L., D.T., M.S., S.M.S.) - both in California; Yale University School of Medicine, Yale Cancer Center, and Smilow Cancer Hospital, New Haven, CT (M.P.D.); the Ireland Cooperative Oncology Research Group, Dublin (J.P.C.); Fudan University Shanghai Cancer Center (Z.S.) and Roche (China) Holding (H.W.), Shanghai; the Cancer Center Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy (E.R.C.); F. Hoffmann-La Roche, Welwyn Garden City, United Kingdom (H.D.); and the NSABP Foundation and Virginia Commonwealth University Massey Cancer Center, Richmond (C.E.G.).; Wolmark N; From the German Breast Group, Neu-Isenburg (G.M., S.L., H.H.F., P.W.), the Center for Hematology and Oncology Bethanien, Frankfurt (S.L.), the AGO-B and HELIOS Klinikum Berlin-Buch, Berlin (M.U.), the National Center for Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg (A.S.), Evangelische Kliniken Gelsenkirchen, Gelsenkirchen (H.H.F.), the Arbeitsgemeinschaft Gynäkologische Onkologie - Breast and Sana Klinikum Offenbach, Offenbach (C.J.), the Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen (P.A.F.), and Mammazentrum Hamburg am Krankenhaus Jerusalem, Hamburg (P.W.) - all in Germany; the National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan (C.-S.H.); Instituto do Câncer do Estado de São Paulo, São Paulo (M.S.M.); the National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation and Orlando Health University of Florida Health Cancer Center, Orlando (E.P.M.); the NSABP Foundation and Allegheny Health Network Cancer Institute (N.W.) and the NSABP Foundation and University of Pittsburgh Cancer Institute, School of Medicine (P.R.), Pittsburgh; Hospital Universitario La Paz-Instituto de Investigación Hospital Universitario La Paz, Madrid (A.R.); Institut Régional du Cancer de Montpellier, Université de Montpellier, INSERM Unité 1194, Montpellier, France (W.J.); the NSABP Foundation and Providence Portland Medical Center, Portland, OR (A.K.C.); the National Cancer Institute, Mexico City (C.A.-S.); the NSABP Foundation and Stanford University School of Medicine, Stanford (I.L.W.), and Genentech, South San Francisco (L.H.L., D.T., M.S., S.M.S.) - both in California; Yale University School of Medicine, Yale Cancer Center, and Smilow Cancer Hospital, New Haven, CT (M.P.D.); the Ireland Cooperative Oncology Research Group, Dublin (J.P.C.); Fudan University Shanghai Cancer Center (Z.S.) and Roche (China) Holding (H.W.), Shanghai; the Cancer Center Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy (E.R.C.); F. Hoffmann-La Roche, Welwyn Garden City, United Kingdom (H.D.); and the NSABP Foundation and Virginia Commonwealth University Massey Cancer Center, Richmond (C.E.G.).; Rastogi P; From the German Breast Group, Neu-Isenburg (G.M., S.L., H.H.F., P.W.), the Center for Hematology and Oncology Bethanien, Frankfurt (S.L.), the AGO-B and HELIOS Klinikum Berlin-Buch, Berlin (M.U.), the National Center for Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg (A.S.), Evangelische Kliniken Gelsenkirchen, Gelsenkirchen (H.H.F.), the Arbeitsgemeinschaft Gynäkologische Onkologie - Breast and Sana Klinikum Offenbach, Offenbach (C.J.), the Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen (P.A.F.), and Mammazentrum Hamburg am Krankenhaus Jerusalem, Hamburg (P.W.) - all in Germany; the National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan (C.-S.H.); Instituto do Câncer do Estado de São Paulo, São Paulo (M.S.M.); the National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation and Orlando Health University of Florida Health Cancer Center, Orlando (E.P.M.); the NSABP Foundation and Allegheny Health Network Cancer Institute (N.W.) and the NSABP Foundation and University of Pittsburgh Cancer Institute, School of Medicine (P.R.), Pittsburgh; Hospital Universitario La Paz-Instituto de Investigación Hospital Universitario La Paz, Madrid (A.R.); Institut Régional du Cancer de Montpellier, Université de Montpellier, INSERM Unité 1194, Montpellier, France (W.J.); the NSABP Foundation and Providence Portland Medical Center, Portland, OR (A.K.C.); the National Cancer Institute, Mexico City (C.A.-S.); the NSABP Foundation and Stanford University School of Medicine, Stanford (I.L.W.), and Genentech, South San Francisco (L.H.L., D.T., M.S., S.M.S.) - both in California; Yale University School of Medicine, Yale Cancer Center, and Smilow Cancer Hospital, New Haven, CT (M.P.D.); the Ireland Cooperative Oncology Research Group, Dublin (J.P.C.); Fudan University Shanghai Cancer Center (Z.S.) and Roche (China) Holding (H.W.), Shanghai; the Cancer Center Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy (E.R.C.); F. Hoffmann-La Roche, Welwyn Garden City, United Kingdom (H.D.); and the NSABP Foundation and Virginia Commonwealth University Massey Cancer Center, Richmond (C.E.G.).; Schneeweiss A; From the German Breast Group, Neu-Isenburg (G.M., S.L., H.H.F., P.W.), the Center for Hematology and Oncology Bethanien, Frankfurt (S.L.), the AGO-B and HELIOS Klinikum Berlin-Buch, Berlin (M.U.), the National Center for Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg (A.S.), Evangelische Kliniken Gelsenkirchen, Gelsenkirchen (H.H.F.), the Arbeitsgemeinschaft Gynäkologische Onkologie - Breast and Sana Klinikum Offenbach, Offenbach (C.J.), the Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen (P.A.F.), and Mammazentrum Hamburg am Krankenhaus Jerusalem, Hamburg (P.W.) - all in Germany; the National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan (C.-S.H.); Instituto do Câncer do Estado de São Paulo, São Paulo (M.S.M.); the National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation and Orlando Health University of Florida Health Cancer Center, Orlando (E.P.M.); the NSABP Foundation and Allegheny Health Network Cancer Institute (N.W.) and the NSABP Foundation and University of Pittsburgh Cancer Institute, School of Medicine (P.R.), Pittsburgh; Hospital Universitario La Paz-Instituto de Investigación Hospital Universitario La Paz, Madrid (A.R.); Institut Régional du Cancer de Montpellier, Université de Montpellier, INSERM Unité 1194, Montpellier, France (W.J.); the NSABP Foundation and Providence Portland Medical Center, Portland, OR (A.K.C.); the National Cancer Institute, Mexico City (C.A.-S.); the NSABP Foundation and Stanford University School of Medicine, Stanford (I.L.W.), and Genentech, South San Francisco (L.H.L., D.T., M.S., S.M.S.) - both in California; Yale University School of Medicine, Yale Cancer Center, and Smilow Cancer Hospital, New Haven, CT (M.P.D.); the Ireland Cooperative Oncology Research Group, Dublin (J.P.C.); Fudan University Shanghai Cancer Center (Z.S.) and Roche (China) Holding (H.W.), Shanghai; the Cancer Center Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy (E.R.C.); F. Hoffmann-La Roche, Welwyn Garden City, United Kingdom (H.D.); and the NSABP Foundation and Virginia Commonwealth University Massey Cancer Center, Richmond (C.E.G.).; Redondo A; From the German Breast Group, Neu-Isenburg (G.M., S.L., H.H.F., P.W.), the Center for Hematology and Oncology Bethanien, Frankfurt (S.L.), the AGO-B and HELIOS Klinikum Berlin-Buch, Berlin (M.U.), the National Center for Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg (A.S.), Evangelische Kliniken Gelsenkirchen, Gelsenkirchen (H.H.F.), the Arbeitsgemeinschaft Gynäkologische Onkologie - Breast and Sana Klinikum Offenbach, Offenbach (C.J.), the Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen (P.A.F.), and Mammazentrum Hamburg am Krankenhaus Jerusalem, Hamburg (P.W.) - all in Germany; the National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan (C.-S.H.); Instituto do Câncer do Estado de São Paulo, São Paulo (M.S.M.); the National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation and Orlando Health University of Florida Health Cancer Center, Orlando (E.P.M.); the NSABP Foundation and Allegheny Health Network Cancer Institute (N.W.) and the NSABP Foundation and University of Pittsburgh Cancer Institute, School of Medicine (P.R.), Pittsburgh; Hospital Universitario La Paz-Instituto de Investigación Hospital Universitario La Paz, Madrid (A.R.); Institut Régional du Cancer de Montpellier, Université de Montpellier, INSERM Unité 1194, Montpellier, France (W.J.); the NSABP Foundation and Providence Portland Medical Center, Portland, OR (A.K.C.); the National Cancer Institute, Mexico City (C.A.-S.); the NSABP Foundation and Stanford University School of Medicine, Stanford (I.L.W.), and Genentech, South San Francisco (L.H.L., D.T., M.S., S.M.S.) - both in California; Yale University School of Medicine, Yale Cancer Center, and Smilow Cancer Hospital, New Haven, CT (M.P.D.); the Ireland Cooperative Oncology Research Group, Dublin (J.P.C.); Fudan University Shanghai Cancer Center (Z.S.) and Roche (China) Holding (H.W.), Shanghai; the Cancer Center Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy (E.R.C.); F. Hoffmann-La Roche, Welwyn Garden City, United Kingdom (H.D.); and the NSABP Foundation and Virginia Commonwealth University Massey Cancer Center, Richmond (C.E.G.).; Fischer HH; From the German Breast Group, Neu-Isenburg (G.M., S.L., H.H.F., P.W.), the Center for Hematology and Oncology Bethanien, Frankfurt (S.L.), the AGO-B and HELIOS Klinikum Berlin-Buch, Berlin (M.U.), the National Center for Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg (A.S.), Evangelische Kliniken Gelsenkirchen, Gelsenkirchen (H.H.F.), the Arbeitsgemeinschaft Gynäkologische Onkologie - Breast and Sana Klinikum Offenbach, Offenbach (C.J.), the Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen (P.A.F.), and Mammazentrum Hamburg am Krankenhaus Jerusalem, Hamburg (P.W.) - all in Germany; the National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan (C.-S.H.); Instituto do Câncer do Estado de São Paulo, São Paulo (M.S.M.); the National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation and Orlando Health University of Florida Health Cancer Center, Orlando (E.P.M.); the NSABP Foundation and Allegheny Health Network Cancer Institute (N.W.) and the NSABP Foundation and University of Pittsburgh Cancer Institute, School of Medicine (P.R.), Pittsburgh; Hospital Universitario La Paz-Instituto de Investigación Hospital Universitario La Paz, Madrid (A.R.); Institut Régional du Cancer de Montpellier, Université de Montpellier, INSERM Unité 1194, Montpellier, France (W.J.); the NSABP Foundation and Providence Portland Medical Center, Portland, OR (A.K.C.); the National Cancer Institute, Mexico City (C.A.-S.); the NSABP Foundation and Stanford University School of Medicine, Stanford (I.L.W.), and Genentech, South San Francisco (L.H.L., D.T., M.S., S.M.S.) - both in California; Yale University School of Medicine, Yale Cancer Center, and Smilow Cancer Hospital, New Haven, CT (M.P.D.); the Ireland Cooperative Oncology Research Group, Dublin (J.P.C.); Fudan University Shanghai Cancer Center (Z.S.) and Roche (China) Holding (H.W.), Shanghai; the Cancer Center Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy (E.R.C.); F. Hoffmann-La Roche, Welwyn Garden City, United Kingdom (H.D.); and the NSABP Foundation and Virginia Commonwealth University Massey Cancer Center, Richmond (C.E.G.).; Jacot W; From the German Breast Group, Neu-Isenburg (G.M., S.L., H.H.F., P.W.), the Center for Hematology and Oncology Bethanien, Frankfurt (S.L.), the AGO-B and HELIOS Klinikum Berlin-Buch, Berlin (M.U.), the National Center for Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg (A.S.), Evangelische Kliniken Gelsenkirchen, Gelsenkirchen (H.H.F.), the Arbeitsgemeinschaft Gynäkologische Onkologie - Breast and Sana Klinikum Offenbach, Offenbach (C.J.), the Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen (P.A.F.), and Mammazentrum Hamburg am Krankenhaus Jerusalem, Hamburg (P.W.) - all in Germany; the National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan (C.-S.H.); Instituto do Câncer do Estado de São Paulo, São Paulo (M.S.M.); the National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation and Orlando Health University of Florida Health Cancer Center, Orlando (E.P.M.); the NSABP Foundation and Allegheny Health Network Cancer Institute (N.W.) and the NSABP Foundation and University of Pittsburgh Cancer Institute, School of Medicine (P.R.), Pittsburgh; Hospital Universitario La Paz-Instituto de Investigación Hospital Universitario La Paz, Madrid (A.R.); Institut Régional du Cancer de Montpellier, Université de Montpellier, INSERM Unité 1194, Montpellier, France (W.J.); the NSABP Foundation and Providence Portland Medical Center, Portland, OR (A.K.C.); the National Cancer Institute, Mexico City (C.A.-S.); the NSABP Foundation and Stanford University School of Medicine, Stanford (I.L.W.), and Genentech, South San Francisco (L.H.L., D.T., M.S., S.M.S.) - both in California; Yale University School of Medicine, Yale Cancer Center, and Smilow Cancer Hospital, New Haven, CT (M.P.D.); the Ireland Cooperative Oncology Research Group, Dublin (J.P.C.); Fudan University Shanghai Cancer Center (Z.S.) and Roche (China) Holding (H.W.), Shanghai; the Cancer Center Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy (E.R.C.); F. Hoffmann-La Roche, Welwyn Garden City, United Kingdom (H.D.); and the NSABP Foundation and Virginia Commonwealth University Massey Cancer Center, Richmond (C.E.G.).; Conlin AK; From the German Breast Group, Neu-Isenburg (G.M., S.L., H.H.F., P.W.), the Center for Hematology and Oncology Bethanien, Frankfurt (S.L.), the AGO-B and HELIOS Klinikum Berlin-Buch, Berlin (M.U.), the National Center for Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg (A.S.), Evangelische Kliniken Gelsenkirchen, Gelsenkirchen (H.H.F.), the Arbeitsgemeinschaft Gynäkologische Onkologie - Breast and Sana Klinikum Offenbach, Offenbach (C.J.), the Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen (P.A.F.), and Mammazentrum Hamburg am Krankenhaus Jerusalem, Hamburg (P.W.) - all in Germany; the National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan (C.-S.H.); Instituto do Câncer do Estado de São Paulo, São Paulo (M.S.M.); the National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation and Orlando Health University of Florida Health Cancer Center, Orlando (E.P.M.); the NSABP Foundation and Allegheny Health Network Cancer Institute (N.W.) and the NSABP Foundation and University of Pittsburgh Cancer Institute, School of Medicine (P.R.), Pittsburgh; Hospital Universitario La Paz-Instituto de Investigación Hospital Universitario La Paz, Madrid (A.R.); Institut Régional du Cancer de Montpellier, Université de Montpellier, INSERM Unité 1194, Montpellier, France (W.J.); the NSABP Foundation and Providence Portland Medical Center, Portland, OR (A.K.C.); the National Cancer Institute, Mexico City (C.A.-S.); the NSABP Foundation and Stanford University School of Medicine, Stanford (I.L.W.), and Genentech, South San Francisco (L.H.L., D.T., M.S., S.M.S.) - both in California; Yale University School of Medicine, Yale Cancer Center, and Smilow Cancer Hospital, New Haven, CT (M.P.D.); the Ireland Cooperative Oncology Research Group, Dublin (J.P.C.); Fudan University Shanghai Cancer Center (Z.S.) and Roche (China) Holding (H.W.), Shanghai; the Cancer Center Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy (E.R.C.); F. Hoffmann-La Roche, Welwyn Garden City, United Kingdom (H.D.); and the NSABP Foundation and Virginia Commonwealth University Massey Cancer Center, Richmond (C.E.G.).; Arce-Salinas C; From the German Breast Group, Neu-Isenburg (G.M., S.L., H.H.F., P.W.), the Center for Hematology and Oncology Bethanien, Frankfurt (S.L.), the AGO-B and HELIOS Klinikum Berlin-Buch, Berlin (M.U.), the National Center for Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg (A.S.), Evangelische Kliniken Gelsenkirchen, Gelsenkirchen (H.H.F.), the Arbeitsgemeinschaft Gynäkologische Onkologie - Breast and Sana Klinikum Offenbach, Offenbach (C.J.), the Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen (P.A.F.), and Mammazentrum Hamburg am Krankenhaus Jerusalem, Hamburg (P.W.) - all in Germany; the National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan (C.-S.H.); Instituto do Câncer do Estado de São Paulo, São Paulo (M.S.M.); the National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation and Orlando Health University of Florida Health Cancer Center, Orlando (E.P.M.); the NSABP Foundation and Allegheny Health Network Cancer Institute (N.W.) and the NSABP Foundation and University of Pittsburgh Cancer Institute, School of Medicine (P.R.), Pittsburgh; Hospital Universitario La Paz-Instituto de Investigación Hospital Universitario La Paz, Madrid (A.R.); Institut Régional du Cancer de Montpellier, Université de Montpellier, INSERM Unité 1194, Montpellier, France (W.J.); the NSABP Foundation and Providence Portland Medical Center, Portland, OR (A.K.C.); the National Cancer Institute, Mexico City (C.A.-S.); the NSABP Foundation and Stanford University School of Medicine, Stanford (I.L.W.), and Genentech, South San Francisco (L.H.L., D.T., M.S., S.M.S.) - both in California; Yale University School of Medicine, Yale Cancer Center, and Smilow Cancer Hospital, New Haven, CT (M.P.D.); the Ireland Cooperative Oncology Research Group, Dublin (J.P.C.); Fudan University Shanghai Cancer Center (Z.S.) and Roche (China) Holding (H.W.), Shanghai; the Cancer Center Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy (E.R.C.); F. Hoffmann-La Roche, Welwyn Garden City, United Kingdom (H.D.); and the NSABP Foundation and Virginia Commonwealth University Massey Cancer Center, Richmond (C.E.G.).; Wapnir IL; From the German Breast Group, Neu-Isenburg (G.M., S.L., H.H.F., P.W.), the Center for Hematology and Oncology Bethanien, Frankfurt (S.L.), the AGO-B and HELIOS Klinikum Berlin-Buch, Berlin (M.U.), the National Center for Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg (A.S.), Evangelische Kliniken Gelsenkirchen, Gelsenkirchen (H.H.F.), the Arbeitsgemeinschaft Gynäkologische Onkologie - Breast and Sana Klinikum Offenbach, Offenbach (C.J.), the Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen (P.A.F.), and Mammazentrum Hamburg am Krankenhaus Jerusalem, Hamburg (P.W.) - all in Germany; the National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan (C.-S.H.); Instituto do Câncer do Estado de São Paulo, São Paulo (M.S.M.); the National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation and Orlando Health University of Florida Health Cancer Center, Orlando (E.P.M.); the NSABP Foundation and Allegheny Health Network Cancer Institute (N.W.) and the NSABP Foundation and University of Pittsburgh Cancer Institute, School of Medicine (P.R.), Pittsburgh; Hospital Universitario La Paz-Instituto de Investigación Hospital Universitario La Paz, Madrid (A.R.); Institut Régional du Cancer de Montpellier, Université de Montpellier, INSERM Unité 1194, Montpellier, France (W.J.); the NSABP Foundation and Providence Portland Medical Center, Portland, OR (A.K.C.); the National Cancer Institute, Mexico City (C.A.-S.); the NSABP Foundation and Stanford University School of Medicine, Stanford (I.L.W.), and Genentech, South San Francisco (L.H.L., D.T., M.S., S.M.S.) - both in California; Yale University School of Medicine, Yale Cancer Center, and Smilow Cancer Hospital, New Haven, CT (M.P.D.); the Ireland Cooperative Oncology Research Group, Dublin (J.P.C.); Fudan University Shanghai Cancer Center (Z.S.) and Roche (China) Holding (H.W.), Shanghai; the Cancer Center Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy (E.R.C.); F. Hoffmann-La Roche, Welwyn Garden City, United Kingdom (H.D.); and the NSABP Foundation and Virginia Commonwealth University Massey Cancer Center, Richmond (C.E.G.).; Jackisch C; From the German Breast Group, Neu-Isenburg (G.M., S.L., H.H.F., P.W.), the Center for Hematology and Oncology Bethanien, Frankfurt (S.L.), the AGO-B and HELIOS Klinikum Berlin-Buch, Berlin (M.U.), the National Center for Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg (A.S.), Evangelische Kliniken Gelsenkirchen, Gelsenkirchen (H.H.F.), the Arbeitsgemeinschaft Gynäkologische Onkologie - Breast and Sana Klinikum Offenbach, Offenbach (C.J.), the Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen (P.A.F.), and Mammazentrum Hamburg am Krankenhaus Jerusalem, Hamburg (P.W.) - all in Germany; the National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan (C.-S.H.); Instituto do Câncer do Estado de São Paulo, São Paulo (M.S.M.); the National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation and Orlando Health University of Florida Health Cancer Center, Orlando (E.P.M.); the NSABP Foundation and Allegheny Health Network Cancer Institute (N.W.) and the NSABP Foundation and University of Pittsburgh Cancer Institute, School of Medicine (P.R.), Pittsburgh; Hospital Universitario La Paz-Instituto de Investigación Hospital Universitario La Paz, Madrid (A.R.); Institut Régional du Cancer de Montpellier, Université de Montpellier, INSERM Unité 1194, Montpellier, France (W.J.); the NSABP Foundation and Providence Portland Medical Center, Portland, OR (A.K.C.); the National Cancer Institute, Mexico City (C.A.-S.); the NSABP Foundation and Stanford University School of Medicine, Stanford (I.L.W.), and Genentech, South San Francisco (L.H.L., D.T., M.S., S.M.S.) - both in California; Yale University School of Medicine, Yale Cancer Center, and Smilow Cancer Hospital, New Haven, CT (M.P.D.); the Ireland Cooperative Oncology Research Group, Dublin (J.P.C.); Fudan University Shanghai Cancer Center (Z.S.) and Roche (China) Holding (H.W.), Shanghai; the Cancer Center Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy (E.R.C.); F. Hoffmann-La Roche, Welwyn Garden City, United Kingdom (H.D.); and the NSABP Foundation and Virginia Commonwealth University Massey Cancer Center, Richmond (C.E.G.).; DiGiovanna MP; From the German Breast Group, Neu-Isenburg (G.M., S.L., H.H.F., P.W.), the Center for Hematology and Oncology Bethanien, Frankfurt (S.L.), the AGO-B and HELIOS Klinikum Berlin-Buch, Berlin (M.U.), the National Center for Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg (A.S.), Evangelische Kliniken Gelsenkirchen, Gelsenkirchen (H.H.F.), the Arbeitsgemeinschaft Gynäkologische Onkologie - Breast and Sana Klinikum Offenbach, Offenbach (C.J.), the Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen (P.A.F.), and Mammazentrum Hamburg am Krankenhaus Jerusalem, Hamburg (P.W.) - all in Germany; the National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan (C.-S.H.); Instituto do Câncer do Estado de São Paulo, São Paulo (M.S.M.); the National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation and Orlando Health University of Florida Health Cancer Center, Orlando (E.P.M.); the NSABP Foundation and Allegheny Health Network Cancer Institute (N.W.) and the NSABP Foundation and University of Pittsburgh Cancer Institute, School of Medicine (P.R.), Pittsburgh; Hospital Universitario La Paz-Instituto de Investigación Hospital Universitario La Paz, Madrid (A.R.); Institut Régional du Cancer de Montpellier, Université de Montpellier, INSERM Unité 1194, Montpellier, France (W.J.); the NSABP Foundation and Providence Portland Medical Center, Portland, OR (A.K.C.); the National Cancer Institute, Mexico City (C.A.-S.); the NSABP Foundation and Stanford University School of Medicine, Stanford (I.L.W.), and Genentech, South San Francisco (L.H.L., D.T., M.S., S.M.S.) - both in California; Yale University School of Medicine, Yale Cancer Center, and Smilow Cancer Hospital, New Haven, CT (M.P.D.); the Ireland Cooperative Oncology Research Group, Dublin (J.P.C.); Fudan University Shanghai Cancer Center (Z.S.) and Roche (China) Holding (H.W.), Shanghai; the Cancer Center Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy (E.R.C.); F. Hoffmann-La Roche, Welwyn Garden City, United Kingdom (H.D.); and the NSABP Foundation and Virginia Commonwealth University Massey Cancer Center, Richmond (C.E.G.).; Fasching PA; From the German Breast Group, Neu-Isenburg (G.M., S.L., H.H.F., P.W.), the Center for Hematology and Oncology Bethanien, Frankfurt (S.L.), the AGO-B and HELIOS Klinikum Berlin-Buch, Berlin (M.U.), the National Center for Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg (A.S.), Evangelische Kliniken Gelsenkirchen, Gelsenkirchen (H.H.F.), the Arbeitsgemeinschaft Gynäkologische Onkologie - Breast and Sana Klinikum Offenbach, Offenbach (C.J.), the Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen (P.A.F.), and Mammazentrum Hamburg am Krankenhaus Jerusalem, Hamburg (P.W.) - all in Germany; the National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan (C.-S.H.); Instituto do Câncer do Estado de São Paulo, São Paulo (M.S.M.); the National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation and Orlando Health University of Florida Health Cancer Center, Orlando (E.P.M.); the NSABP Foundation and Allegheny Health Network Cancer Institute (N.W.) and the NSABP Foundation and University of Pittsburgh Cancer Institute, School of Medicine (P.R.), Pittsburgh; Hospital Universitario La Paz-Instituto de Investigación Hospital Universitario La Paz, Madrid (A.R.); Institut Régional du Cancer de Montpellier, Université de Montpellier, INSERM Unité 1194, Montpellier, France (W.J.); the NSABP Foundation and Providence Portland Medical Center, Portland, OR (A.K.C.); the National Cancer Institute, Mexico City (C.A.-S.); the NSABP Foundation and Stanford University School of Medicine, Stanford (I.L.W.), and Genentech, South San Francisco (L.H.L., D.T., M.S., S.M.S.) - both in California; Yale University School of Medicine, Yale Cancer Center, and Smilow Cancer Hospital, New Haven, CT (M.P.D.); the Ireland Cooperative Oncology Research Group, Dublin (J.P.C.); Fudan University Shanghai Cancer Center (Z.S.) and Roche (China) Holding (H.W.), Shanghai; the Cancer Center Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy (E.R.C.); F. Hoffmann-La Roche, Welwyn Garden City, United Kingdom (H.D.); and the NSABP Foundation and Virginia Commonwealth University Massey Cancer Center, Richmond (C.E.G.).; Crown JP; From the German Breast Group, Neu-Isenburg (G.M., S.L., H.H.F., P.W.), the Center for Hematology and Oncology Bethanien, Frankfurt (S.L.), the AGO-B and HELIOS Klinikum Berlin-Buch, Berlin (M.U.), the National Center for Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg (A.S.), Evangelische Kliniken Gelsenkirchen, Gelsenkirchen (H.H.F.), the Arbeitsgemeinschaft Gynäkologische Onkologie - Breast and Sana Klinikum Offenbach, Offenbach (C.J.), the Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen (P.A.F.), and Mammazentrum Hamburg am Krankenhaus Jerusalem, Hamburg (P.W.) - all in Germany; the National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan (C.-S.H.); Instituto do Câncer do Estado de São Paulo, São Paulo (M.S.M.); the National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation and Orlando Health University of Florida Health Cancer Center, Orlando (E.P.M.); the NSABP Foundation and Allegheny Health Network Cancer Institute (N.W.) and the NSABP Foundation and University of Pittsburgh Cancer Institute, School of Medicine (P.R.), Pittsburgh; Hospital Universitario La Paz-Instituto de Investigación Hospital Universitario La Paz, Madrid (A.R.); Institut Régional du Cancer de Montpellier, Université de Montpellier, INSERM Unité 1194, Montpellier, France (W.J.); the NSABP Foundation and Providence Portland Medical Center, Portland, OR (A.K.C.); the National Cancer Institute, Mexico City (C.A.-S.); the NSABP Foundation and Stanford University School of Medicine, Stanford (I.L.W.), and Genentech, South San Francisco (L.H.L., D.T., M.S., S.M.S.) - both in California; Yale University School of Medicine, Yale Cancer Center, and Smilow Cancer Hospital, New Haven, CT (M.P.D.); the Ireland Cooperative Oncology Research Group, Dublin (J.P.C.); Fudan University Shanghai Cancer Center (Z.S.) and Roche (China) Holding (H.W.), Shanghai; the Cancer Center Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy (E.R.C.); F. Hoffmann-La Roche, Welwyn Garden City, United Kingdom (H.D.); and the NSABP Foundation and Virginia Commonwealth University Massey Cancer Center, Richmond (C.E.G.).; Wülfing P; From the German Breast Group, Neu-Isenburg (G.M., S.L., H.H.F., P.W.), the Center for Hematology and Oncology Bethanien, Frankfurt (S.L.), the AGO-B and HELIOS Klinikum Berlin-Buch, Berlin (M.U.), the National Center for Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg (A.S.), Evangelische Kliniken Gelsenkirchen, Gelsenkirchen (H.H.F.), the Arbeitsgemeinschaft Gynäkologische Onkologie - Breast and Sana Klinikum Offenbach, Offenbach (C.J.), the Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen (P.A.F.), and Mammazentrum Hamburg am Krankenhaus Jerusalem, Hamburg (P.W.) - all in Germany; the National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan (C.-S.H.); Instituto do Câncer do Estado de São Paulo, São Paulo (M.S.M.); the National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation and Orlando Health University of Florida Health Cancer Center, Orlando (E.P.M.); the NSABP Foundation and Allegheny Health Network Cancer Institute (N.W.) and the NSABP Foundation and University of Pittsburgh Cancer Institute, School of Medicine (P.R.), Pittsburgh; Hospital Universitario La Paz-Instituto de Investigación Hospital Universitario La Paz, Madrid (A.R.); Institut Régional du Cancer de Montpellier, Université de Montpellier, INSERM Unité 1194, Montpellier, France (W.J.); the NSABP Foundation and Providence Portland Medical Center, Portland, OR (A.K.C.); the National Cancer Institute, Mexico City (C.A.-S.); the NSABP Foundation and Stanford University School of Medicine, Stanford (I.L.W.), and Genentech, South San Francisco (L.H.L., D.T., M.S., S.M.S.) - both in California; Yale University School of Medicine, Yale Cancer Center, and Smilow Cancer Hospital, New Haven, CT (M.P.D.); the Ireland Cooperative Oncology Research Group, Dublin (J.P.C.); Fudan University Shanghai Cancer Center (Z.S.) and Roche (China) Holding (H.W.), Shanghai; the Cancer Center Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy (E.R.C.); F. Hoffmann-La Roche, Welwyn Garden City, United Kingdom (H.D.); and the NSABP Foundation and Virginia Commonwealth University Massey Cancer Center, Richmond (C.E.G.).; Shao Z; From the German Breast Group, Neu-Isenburg (G.M., S.L., H.H.F., P.W.), the Center for Hematology and Oncology Bethanien, Frankfurt (S.L.), the AGO-B and HELIOS Klinikum Berlin-Buch, Berlin (M.U.), the National Center for Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg (A.S.), Evangelische Kliniken Gelsenkirchen, Gelsenkirchen (H.H.F.), the Arbeitsgemeinschaft Gynäkologische Onkologie - Breast and Sana Klinikum Offenbach, Offenbach (C.J.), the Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen (P.A.F.), and Mammazentrum Hamburg am Krankenhaus Jerusalem, Hamburg (P.W.) - all in Germany; the National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan (C.-S.H.); Instituto do Câncer do Estado de São Paulo, São Paulo (M.S.M.); the National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation and Orlando Health University of Florida Health Cancer Center, Orlando (E.P.M.); the NSABP Foundation and Allegheny Health Network Cancer Institute (N.W.) and the NSABP Foundation and University of Pittsburgh Cancer Institute, School of Medicine (P.R.), Pittsburgh; Hospital Universitario La Paz-Instituto de Investigación Hospital Universitario La Paz, Madrid (A.R.); Institut Régional du Cancer de Montpellier, Université de Montpellier, INSERM Unité 1194, Montpellier, France (W.J.); the NSABP Foundation and Providence Portland Medical Center, Portland, OR (A.K.C.); the National Cancer Institute, Mexico City (C.A.-S.); the NSABP Foundation and Stanford University School of Medicine, Stanford (I.L.W.), and Genentech, South San Francisco (L.H.L., D.T., M.S., S.M.S.) - both in California; Yale University School of Medicine, Yale Cancer Center, and Smilow Cancer Hospital, New Haven, CT (M.P.D.); the Ireland Cooperative Oncology Research Group, Dublin (J.P.C.); Fudan University Shanghai Cancer Center (Z.S.) and Roche (China) Holding (H.W.), Shanghai; the Cancer Center Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy (E.R.C.); F. Hoffmann-La Roche, Welwyn Garden City, United Kingdom (H.D.); and the NSABP Foundation and Virginia Commonwealth University Massey Cancer Center, Richmond (C.E.G.).; Rota Caremoli E; From the German Breast Group, Neu-Isenburg (G.M., S.L., H.H.F., P.W.), the Center for Hematology and Oncology Bethanien, Frankfurt (S.L.), the AGO-B and HELIOS Klinikum Berlin-Buch, Berlin (M.U.), the National Center for Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg (A.S.), Evangelische Kliniken Gelsenkirchen, Gelsenkirchen (H.H.F.), the Arbeitsgemeinschaft Gynäkologische Onkologie - Breast and Sana Klinikum Offenbach, Offenbach (C.J.), the Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen (P.A.F.), and Mammazentrum Hamburg am Krankenhaus Jerusalem, Hamburg (P.W.) - all in Germany; the National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan (C.-S.H.); Instituto do Câncer do Estado de São Paulo, São Paulo (M.S.M.); the National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation and Orlando Health University of Florida Health Cancer Center, Orlando (E.P.M.); the NSABP Foundation and Allegheny Health Network Cancer Institute (N.W.) and the NSABP Foundation and University of Pittsburgh Cancer Institute, School of Medicine (P.R.), Pittsburgh; Hospital Universitario La Paz-Instituto de Investigación Hospital Universitario La Paz, Madrid (A.R.); Institut Régional du Cancer de Montpellier, Université de Montpellier, INSERM Unité 1194, Montpellier, France (W.J.); the NSABP Foundation and Providence Portland Medical Center, Portland, OR (A.K.C.); the National Cancer Institute, Mexico City (C.A.-S.); the NSABP Foundation and Stanford University School of Medicine, Stanford (I.L.W.), and Genentech, South San Francisco (L.H.L., D.T., M.S., S.M.S.) - both in California; Yale University School of Medicine, Yale Cancer Center, and Smilow Cancer Hospital, New Haven, CT (M.P.D.); the Ireland Cooperative Oncology Research Group, Dublin (J.P.C.); Fudan University Shanghai Cancer Center (Z.S.) and Roche (China) Holding (H.W.), Shanghai; the Cancer Center Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy (E.R.C.); F. Hoffmann-La Roche, Welwyn Garden City, United Kingdom (H.D.); and the NSABP Foundation and Virginia Commonwealth University Massey Cancer Center, Richmond (C.E.G.).; Wu H; From the German Breast Group, Neu-Isenburg (G.M., S.L., H.H.F., P.W.), the Center for Hematology and Oncology Bethanien, Frankfurt (S.L.), the AGO-B and HELIOS Klinikum Berlin-Buch, Berlin (M.U.), the National Center for Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg (A.S.), Evangelische Kliniken Gelsenkirchen, Gelsenkirchen (H.H.F.), the Arbeitsgemeinschaft Gynäkologische Onkologie - Breast and Sana Klinikum Offenbach, Offenbach (C.J.), the Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen (P.A.F.), and Mammazentrum Hamburg am Krankenhaus Jerusalem, Hamburg (P.W.) - all in Germany; the National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan (C.-S.H.); Instituto do Câncer do Estado de São Paulo, São Paulo (M.S.M.); the National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation and Orlando Health University of Florida Health Cancer Center, Orlando (E.P.M.); the NSABP Foundation and Allegheny Health Network Cancer Institute (N.W.) and the NSABP Foundation and University of Pittsburgh Cancer Institute, School of Medicine (P.R.), Pittsburgh; Hospital Universitario La Paz-Instituto de Investigación Hospital Universitario La Paz, Madrid (A.R.); Institut Régional du Cancer de Montpellier, Université de Montpellier, INSERM Unité 1194, Montpellier, France (W.J.); the NSABP Foundation and Providence Portland Medical Center, Portland, OR (A.K.C.); the National Cancer Institute, Mexico City (C.A.-S.); the NSABP Foundation and Stanford University School of Medicine, Stanford (I.L.W.), and Genentech, South San Francisco (L.H.L., D.T., M.S., S.M.S.) - both in California; Yale University School of Medicine, Yale Cancer Center, and Smilow Cancer Hospital, New Haven, CT (M.P.D.); the Ireland Cooperative Oncology Research Group, Dublin (J.P.C.); Fudan University Shanghai Cancer Center (Z.S.) and Roche (China) Holding (H.W.), Shanghai; the Cancer Center Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy (E.R.C.); F. Hoffmann-La Roche, Welwyn Garden City, United Kingdom (H.D.); and the NSABP Foundation and Virginia Commonwealth University Massey Cancer Center, Richmond (C.E.G.).; Lam LH; From the German Breast Group, Neu-Isenburg (G.M., S.L., H.H.F., P.W.), the Center for Hematology and Oncology Bethanien, Frankfurt (S.L.), the AGO-B and HELIOS Klinikum Berlin-Buch, Berlin (M.U.), the National Center for Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg (A.S.), Evangelische Kliniken Gelsenkirchen, Gelsenkirchen (H.H.F.), the Arbeitsgemeinschaft Gynäkologische Onkologie - Breast and Sana Klinikum Offenbach, Offenbach (C.J.), the Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen (P.A.F.), and Mammazentrum Hamburg am Krankenhaus Jerusalem, Hamburg (P.W.) - all in Germany; the National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan (C.-S.H.); Instituto do Câncer do Estado de São Paulo, São Paulo (M.S.M.); the National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation and Orlando Health University of Florida Health Cancer Center, Orlando (E.P.M.); the NSABP Foundation and Allegheny Health Network Cancer Institute (N.W.) and the NSABP Foundation and University of Pittsburgh Cancer Institute, School of Medicine (P.R.), Pittsburgh; Hospital Universitario La Paz-Instituto de Investigación Hospital Universitario La Paz, Madrid (A.R.); Institut Régional du Cancer de Montpellier, Université de Montpellier, INSERM Unité 1194, Montpellier, France (W.J.); the NSABP Foundation and Providence Portland Medical Center, Portland, OR (A.K.C.); the National Cancer Institute, Mexico City (C.A.-S.); the NSABP Foundation and Stanford University School of Medicine, Stanford (I.L.W.), and Genentech, South San Francisco (L.H.L., D.T., M.S., S.M.S.) - both in California; Yale University School of Medicine, Yale Cancer Center, and Smilow Cancer Hospital, New Haven, CT (M.P.D.); the Ireland Cooperative Oncology Research Group, Dublin (J.P.C.); Fudan University Shanghai Cancer Center (Z.S.) and Roche (China) Holding (H.W.), Shanghai; the Cancer Center Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy (E.R.C.); F. Hoffmann-La Roche, Welwyn Garden City, United Kingdom (H.D.); and the NSABP Foundation and Virginia Commonwealth University Massey Cancer Center, Richmond (C.E.G.).; Tesarowski D; From the German Breast Group, Neu-Isenburg (G.M., S.L., H.H.F., P.W.), the Center for Hematology and Oncology Bethanien, Frankfurt (S.L.), the AGO-B and HELIOS Klinikum Berlin-Buch, Berlin (M.U.), the National Center for Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg (A.S.), Evangelische Kliniken Gelsenkirchen, Gelsenkirchen (H.H.F.), the Arbeitsgemeinschaft Gynäkologische Onkologie - Breast and Sana Klinikum Offenbach, Offenbach (C.J.), the Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen (P.A.F.), and Mammazentrum Hamburg am Krankenhaus Jerusalem, Hamburg (P.W.) - all in Germany; the National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan (C.-S.H.); Instituto do Câncer do Estado de São Paulo, São Paulo (M.S.M.); the National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation and Orlando Health University of Florida Health Cancer Center, Orlando (E.P.M.); the NSABP Foundation and Allegheny Health Network Cancer Institute (N.W.) and the NSABP Foundation and University of Pittsburgh Cancer Institute, School of Medicine (P.R.), Pittsburgh; Hospital Universitario La Paz-Instituto de Investigación Hospital Universitario La Paz, Madrid (A.R.); Institut Régional du Cancer de Montpellier, Université de Montpellier, INSERM Unité 1194, Montpellier, France (W.J.); the NSABP Foundation and Providence Portland Medical Center, Portland, OR (A.K.C.); the National Cancer Institute, Mexico City (C.A.-S.); the NSABP Foundation and Stanford University School of Medicine, Stanford (I.L.W.), and Genentech, South San Francisco (L.H.L., D.T., M.S., S.M.S.) - both in California; Yale University School of Medicine, Yale Cancer Center, and Smilow Cancer Hospital, New Haven, CT (M.P.D.); the Ireland Cooperative Oncology Research Group, Dublin (J.P.C.); Fudan University Shanghai Cancer Center (Z.S.) and Roche (China) Holding (H.W.), Shanghai; the Cancer Center Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy (E.R.C.); F. Hoffmann-La Roche, Welwyn Garden City, United Kingdom (H.D.); and the NSABP Foundation and Virginia Commonwealth University Massey Cancer Center, Richmond (C.E.G.).; Smitt M; From the German Breast Group, Neu-Isenburg (G.M., S.L., H.H.F., P.W.), the Center for Hematology and Oncology Bethanien, Frankfurt (S.L.), the AGO-B and HELIOS Klinikum Berlin-Buch, Berlin (M.U.), the National Center for Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg (A.S.), Evangelische Kliniken Gelsenkirchen, Gelsenkirchen (H.H.F.), the Arbeitsgemeinschaft Gynäkologische Onkologie - Breast and Sana Klinikum Offenbach, Offenbach (C.J.), the Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen (P.A.F.), and Mammazentrum Hamburg am Krankenhaus Jerusalem, Hamburg (P.W.) - all in Germany; the National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan (C.-S.H.); Instituto do Câncer do Estado de São Paulo, São Paulo (M.S.M.); the National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation and Orlando Health University of Florida Health Cancer Center, Orlando (E.P.M.); the NSABP Foundation and Allegheny Health Network Cancer Institute (N.W.) and the NSABP Foundation and University of Pittsburgh Cancer Institute, School of Medicine (P.R.), Pittsburgh; Hospital Universitario La Paz-Instituto de Investigación Hospital Universitario La Paz, Madrid (A.R.); Institut Régional du Cancer de Montpellier, Université de Montpellier, INSERM Unité 1194, Montpellier, France (W.J.); the NSABP Foundation and Providence Portland Medical Center, Portland, OR (A.K.C.); the National Cancer Institute, Mexico City (C.A.-S.); the NSABP Foundation and Stanford University School of Medicine, Stanford (I.L.W.), and Genentech, South San Francisco (L.H.L., D.T., M.S., S.M.S.) - both in California; Yale University School of Medicine, Yale Cancer Center, and Smilow Cancer Hospital, New Haven, CT (M.P.D.); the Ireland Cooperative Oncology Research Group, Dublin (J.P.C.); Fudan University Shanghai Cancer Center (Z.S.) and Roche (China) Holding (H.W.), Shanghai; the Cancer Center Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy (E.R.C.); F. Hoffmann-La Roche, Welwyn Garden City, United Kingdom (H.D.); and the NSABP Foundation and Virginia Commonwealth University Massey Cancer Center, Richmond (C.E.G.).; Douthwaite H; From the German Breast Group, Neu-Isenburg (G.M., S.L., H.H.F., P.W.), the Center for Hematology and Oncology Bethanien, Frankfurt (S.L.), the AGO-B and HELIOS Klinikum Berlin-Buch, Berlin (M.U.), the National Center for Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg (A.S.), Evangelische Kliniken Gelsenkirchen, Gelsenkirchen (H.H.F.), the Arbeitsgemeinschaft Gynäkologische Onkologie - Breast and Sana Klinikum Offenbach, Offenbach (C.J.), the Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen (P.A.F.), and Mammazentrum Hamburg am Krankenhaus Jerusalem, Hamburg (P.W.) - all in Germany; the National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan (C.-S.H.); Instituto do Câncer do Estado de São Paulo, São Paulo (M.S.M.); the National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation and Orlando Health University of Florida Health Cancer Center, Orlando (E.P.M.); the NSABP Foundation and Allegheny Health Network Cancer Institute (N.W.) and the NSABP Foundation and University of Pittsburgh Cancer Institute, School of Medicine (P.R.), Pittsburgh; Hospital Universitario La Paz-Instituto de Investigación Hospital Universitario La Paz, Madrid (A.R.); Institut Régional du Cancer de Montpellier, Université de Montpellier, INSERM Unité 1194, Montpellier, France (W.J.); the NSABP Foundation and Providence Portland Medical Center, Portland, OR (A.K.C.); the National Cancer Institute, Mexico City (C.A.-S.); the NSABP Foundation and Stanford University School of Medicine, Stanford (I.L.W.), and Genentech, South San Francisco (L.H.L., D.T., M.S., S.M.S.) - both in California; Yale University School of Medicine, Yale Cancer Center, and Smilow Cancer Hospital, New Haven, CT (M.P.D.); the Ireland Cooperative Oncology Research Group, Dublin (J.P.C.); Fudan University Shanghai Cancer Center (Z.S.) and Roche (China) Holding (H.W.), Shanghai; the Cancer Center Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy (E.R.C.); F. Hoffmann-La Roche, Welwyn Garden City, United Kingdom (H.D.); and the NSABP Foundation and Virginia Commonwealth University Massey Cancer Center, Richmond (C.E.G.).; Singel SM; From the German Breast Group, Neu-Isenburg (G.M., S.L., H.H.F., P.W.), the Center for Hematology and Oncology Bethanien, Frankfurt (S.L.), the AGO-B and HELIOS Klinikum Berlin-Buch, Berlin (M.U.), the National Center for Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg (A.S.), Evangelische Kliniken Gelsenkirchen, Gelsenkirchen (H.H.F.), the Arbeitsgemeinschaft Gynäkologische Onkologie - Breast and Sana Klinikum Offenbach, Offenbach (C.J.), the Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen (P.A.F.), and Mammazentrum Hamburg am Krankenhaus Jerusalem, Hamburg (P.W.) - all in Germany; the National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan (C.-S.H.); Instituto do Câncer do Estado de São Paulo, São Paulo (M.S.M.); the National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation and Orlando Health University of Florida Health Cancer Center, Orlando (E.P.M.); the NSABP Foundation and Allegheny Health Network Cancer Institute (N.W.) and the NSABP Foundation and University of Pittsburgh Cancer Institute, School of Medicine (P.R.), Pittsburgh; Hospital Universitario La Paz-Instituto de Investigación Hospital Universitario La Paz, Madrid (A.R.); Institut Régional du Cancer de Montpellier, Université de Montpellier, INSERM Unité 1194, Montpellier, France (W.J.); the NSABP Foundation and Providence Portland Medical Center, Portland, OR (A.K.C.); the National Cancer Institute, Mexico City (C.A.-S.); the NSABP Foundation and Stanford University School of Medicine, Stanford (I.L.W.), and Genentech, South San Francisco (L.H.L., D.T., M.S., S.M.S.) - both in California; Yale University School of Medicine, Yale Cancer Center, and Smilow Cancer Hospital, New Haven, CT (M.P.D.); the Ireland Cooperative Oncology Research Group, Dublin (J.P.C.); Fudan University Shanghai Cancer Center (Z.S.) and Roche (China) Holding (H.W.), Shanghai; the Cancer Center Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy (E.R.C.); F. Hoffmann-La Roche, Welwyn Garden City, United Kingdom (H.D.); and the NSABP Foundation and Virginia Commonwealth University Massey Cancer Center, Richmond (C.E.G.).; Geyer CE Jr; From the German Breast Group, Neu-Isenburg (G.M., S.L., H.H.F., P.W.), the Center for Hematology and Oncology Bethanien, Frankfurt (S.L.), the AGO-B and HELIOS Klinikum Berlin-Buch, Berlin (M.U.), the National Center for Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg (A.S.), Evangelische Kliniken Gelsenkirchen, Gelsenkirchen (H.H.F.), the Arbeitsgemeinschaft Gynäkologische Onkologie - Breast and Sana Klinikum Offenbach, Offenbach (C.J.), the Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen (P.A.F.), and Mammazentrum Hamburg am Krankenhaus Jerusalem, Hamburg (P.W.) - all in Germany; the National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan (C.-S.H.); Instituto do Câncer do Estado de São Paulo, São Paulo (M.S.M.); the National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation and Orlando Health University of Florida Health Cancer Center, Orlando (E.P.M.); the NSABP Foundation and Allegheny Health Network Cancer Institute (N.W.) and the NSABP Foundation and University of Pittsburgh Cancer Institute, School of Medicine (P.R.), Pittsburgh; Hospital Universitario La Paz-Instituto de Investigación Hospital Universitario La Paz, Madrid (A.R.); Institut Régional du Cancer de Montpellier, Université de Montpellier, INSERM Unité 1194, Montpellier, France (W.J.); the NSABP Foundation and Providence Portland Medical Center, Portland, OR (A.K.C.); the National Cancer Institute, Mexico City (C.A.-S.); the NSABP Foundation and Stanford University School of Medicine, Stanford (I.L.W.), and Genentech, South San Francisco (L.H.L., D.T., M.S., S.M.S.) - both in California; Yale University School of Medicine, Yale Cancer Center, and Smilow Cancer Hospital, New Haven, CT (M.P.D.); the Ireland Cooperative Oncology Research Group, Dublin (J.P.C.); Fudan University Shanghai Cancer Center (Z.S.) and Roche (China) Holding (H.W.), Shanghai; the Cancer Center Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy (E.R.C.); F. Hoffmann-La Roche, Welwyn Garden City, United Kingdom (H.D.); and the NSABP Foundation and Virginia Commonwealth University Massey Cancer Center, Richmond (C.E.G.).
Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE
Academic Journal
Lin NU; Dana-Farber Cancer Institute, Boston, MA.; Borges V; University of Colorado Cancer Center, Aurora, CO.; Anders C; Duke Cancer Institute, Durham, NC.; Murthy RK; MD Anderson Cancer Center, Houston, TX.; Paplomata E; Carbone Cancer Center/University of Wisconsin, Madison, WI.; Hamilton E; Sarah Cannon Research Institute/Tennessee Oncology-Nashville, Nashville, TN.; Hurvitz S; University of California Los Angeles Medical Center/Jonsson Comprehensive Cancer Center, Los Angeles, CA.; Loi S; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Okines A; Royal Marsden National Health Service (NHS) Foundation Trust, London, United Kingdom.; Abramson V; Vanderbilt University Medical Center, Nashville, TN.; Bedard PL; University Health Network, Princess Margaret Cancer Centre, Toronto, ON, Canada.; Oliveira M; Hospital Universitario Vall D'Hebron, Barcelona, Spain.; Mueller V; Universitaetsklinikum Hamburg-Eppendorf, Hamburg, Germany.; Zelnak A; Northside Hospital, Atlanta, GA.; DiGiovanna MP; Yale Cancer Center/Smilow Cancer Hospital, New Haven, CT.; Bachelot T; Centre Léon Bérard, Lyon, France.; Chien AJ; University of California at San Francisco, San Francisco, CA.; O'Regan R; Carbone Cancer Center/University of Wisconsin, Madison, WI.; Wardley A; Christie NHS Foundation Trust, Manchester Academic Health Science Centre & Division of Cancer Sciences, School of Medical Sciences, University of Manchester, Manchester, United Kingdom.; Conlin A; Providence Cancer Institute, Portland, OR.; Cameron D; Edinburgh Cancer Research Centre, Edinburgh, United Kingdom.; Carey L; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC.; Curigliano G; Istituto Europeo di Oncologia, Istituto di Ricovero e Cura a Carattere Scientifico, University of Milano, Milan, Italy.; Gelmon K; British Columbia Cancer-Vancouver Centre, Vancouver, BC, Canada.; Loibl S; German Breast Group, Neu-Isenburg, Germany.; Mayor J; Seattle Genetics, Bothell, WA.; McGoldrick S; Seattle Genetics, Bothell, WA.; An X; Seattle Genetics, Bothell, WA.; Winer EP; Dana-Farber Cancer Institute, Boston, MA.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Academic Journal
Gale M; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.; Li Y; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.; Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China.; Cao J; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.; Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut.; Liu ZZ; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.; Holmbeck MA; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.; Zhang M; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.; Lang SM; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.; Wu L; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.; Do Carmo M; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.; Gupta S; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.; Aoshima K; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.; Laboratory of Comparative Pathology, Department of Clinical Veterinary Sciences, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Hokkaido, Japan.; DiGiovanna MP; Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut.; Section of Medical Oncology, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.; Stern DF; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.; Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut.; Rimm DL; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.; Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut.; Shadel GS; Salk Institute for Biological Studies, La Jolla, California.; Chen X; Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China. qin.yan@yale.edu chenxiangck@126.com.; Hunan Key Laboratory of Skin Cancer and Psoriasis, Changsha, Hunan, China.; Yan Q; Department of Pathology, Yale School of Medicine, New Haven, Connecticut. qin.yan@yale.edu chenxiangck@126.com.; Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut.; Yale Stem Cell Center, Yale School of Medicine, New Haven, Connecticut.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE
Academic Journal
Pusztai L; Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA. Electronic address: lajos.pusztai@yale.edu.; Foldi J; Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA.; Dhawan A; Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA.; DiGiovanna MP; Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA.; Mamounas EP; Orlando Health, University of Florida Health Cancer Center, Orlando, FL, USA.
Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE
Academic Journal
Trant AA; Yale School of Medicine, 333 Cedar St., PO Box 208032, New Haven, CT, 05620, USA.; Szekely B; National Institute of Oncology, New Haven, USA.; Mougalian SS; Yale School of Medicine, 333 Cedar St., PO Box 208032, New Haven, CT, 05620, USA.; DiGiovanna MP; Yale School of Medicine, 333 Cedar St., PO Box 208032, New Haven, CT, 05620, USA.; Sanft T; Yale School of Medicine, 333 Cedar St., PO Box 208032, New Haven, CT, 05620, USA.; Hofstatter E; Yale School of Medicine, 333 Cedar St., PO Box 208032, New Haven, CT, 05620, USA.; Silber A; Yale School of Medicine, 333 Cedar St., PO Box 208032, New Haven, CT, 05620, USA.; Adelson KB; Yale School of Medicine, 333 Cedar St., PO Box 208032, New Haven, CT, 05620, USA.; Chagpar A; Yale School of Medicine, 333 Cedar St., PO Box 208032, New Haven, CT, 05620, USA.; Killelea B; Yale School of Medicine, 333 Cedar St., PO Box 208032, New Haven, CT, 05620, USA.; Horowitz N; Yale School of Medicine, 333 Cedar St., PO Box 208032, New Haven, CT, 05620, USA.; Lannin D; Yale School of Medicine, 333 Cedar St., PO Box 208032, New Haven, CT, 05620, USA.; Park T; Yale School of Medicine, 333 Cedar St., PO Box 208032, New Haven, CT, 05620, USA.; Corso M; Yale-New Haven Health System, New Haven, USA.; Abraham G; Yale-New Haven Health System, New Haven, USA.; Pollard-Murphy K; St. Mary's Hospital, Waterbury, USA.; Sturrock T; Yale-New Haven Health System, New Haven, USA.; Knill-Selby E; Yale-New Haven Health System, New Haven, USA.; Western A; Yale-New Haven Health System, New Haven, USA.; Servodidio C; Yale-New Haven Health System, New Haven, USA.; Tasoulis MK; The Royal Marsden NHS Foundation Trust, London, UK.; Healy B; Barbara Healy Associates, Cheshire, USA.; Hatzis C; Yale School of Medicine, 333 Cedar St., PO Box 208032, New Haven, CT, 05620, USA.; Pusztai L; Yale School of Medicine, 333 Cedar St., PO Box 208032, New Haven, CT, 05620, USA. lajos.pusztai@yale.edu.
Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] DiGiovanna MP
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어